Supplies - 274817-2019

13/06/2019    S112    - - Supplies - Contract award notice - Open procedure 

Finland-Helsinki: Vaccines

2019/S 112-274817

Contract award notice

Results of the procurement procedure

Supplies

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses
National Institute for Health and Welfare
2229500-6
PL 30
Helsinki
00271
Finland
E-mail: jenni.tiainen@thl.fi
NUTS code: FI1B

Internet address(es):

Main address: https://thl.fi/en/web/thlfi-en

I.2)Information about joint procurement
I.4)Type of the contracting authority
National or federal agency/office
I.5)Main activity
Health

Section II: Object

II.1)Scope of the procurement
II.1.1)Title:

Contract for the Procurement of Human Papillomavirus Vaccine (HPV) 2019-2020 (2020-2021)

Reference number: THL/1722/8.00.02/2018
II.1.2)Main CPV code
33651600
II.1.3)Type of contract
Supplies
II.1.4)Short description:

The Ministry of Social Affairs and Health (hereinafter ‘STM’) and National Institute for Health and Welfare (hereinafter ‘THL’ or ‘Customer’) request your tender for Human Papillomavirus Vaccine (HPV) belonging to the National Vaccination Programme in Finland. The contract period is 1 year (during 2019-2020). The extend of the contract (option period) is one year (during 2020-2021). Estimated quantity for the contract period including option is 94 000 doses. The customer reserves the right to increase or decrease the ordered numbers of doses by up to 20 %. The customer will choose the supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The tenderer that quoted the lowest reference price per dose will be awarded the contract.

II.1.6)Information about lots
This contract is divided into lots: no
II.1.7)Total value of the procurement (excluding VAT)
Value excluding VAT: 1 447 600.00 EUR
II.2)Description
II.2.1)Title:
II.2.2)Additional CPV code(s)
II.2.3)Place of performance
NUTS code: FI
II.2.4)Description of the procurement:

The purpose of STM and the customer is to procure Human Papillomavirus Vaccine (HPV) required for the National Vaccination Programme in Finland. The Customer will implement the procurement on STM's side. The roles of STM and customer are described in more detail in section ‘Presentation of the Contracting Authority’. The subject of procurement and the mandatory requirements relating to it are described in detail in this invitation to tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders. Contract period: the contract period is 1 year (during 2019-2020). The contract period shall enter into force once the contract has been signed, and expire when all contractual duties have been performed. Please notice that in the Section ‘II.2.5. Award criteria’ Price means the reference price. Tenders will be compared in the manner described in section ‘Grounds for decision’ of the invitation to tender.

II.2.5)Award criteria
Price
II.2.11)Information about options
Options: yes
Description of options:

If the customer decides to exercise the option, the supplier is committed to the following extensions of the contract: The extend of the contract (option period) is 1 year (during 2020-2021).

II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

This procurement is detailed in the Contract Notice published on TED (Tenders Electronic Daily) online version and on the HILMA advertisement website as well as this Invitation to tender and its Annexes.

Section IV: Procedure

IV.1)Description
IV.1.1)Type of procedure
Open procedure
IV.1.3)Information about a framework agreement or a dynamic purchasing system
IV.1.6)Information about electronic auction
IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: yes
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure
Notice number in the OJ S: 2018/S 214-489934
IV.2.8)Information about termination of dynamic purchasing system
IV.2.9)Information about termination of call for competition in the form of a prior information notice

Section V: Award of contract

Title:

Contract for the Procurement of Human Papillomavirus Vaccine (HPV) 2019-2020 (2020-2021)

A contract/lot is awarded: yes
V.2)Award of contract
V.2.1)Date of conclusion of the contract:
25/03/2019
V.2.2)Information about tenders
Number of tenders received: 2
The contract has been awarded to a group of economic operators: no
V.2.3)Name and address of the contractor
GlaxoSmithKline Oy
01083784
Espoo
Finland
NUTS code: FI
The contractor is an SME: no
V.2.4)Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot: 1 447 600.00 EUR
V.2.5)Information about subcontracting

Section VI: Complementary information

VI.3)Additional information:

Tenderers may ask clarification questions using the supplier portal. The questions must be in English and will be answered in English. To guarantee the equal treatment of tenderers, questions posed in any other way cannot be answered. All times given in the invitation to tender are local time in Finland. Please note that the online connection to the supplier portal is periodically slow and the download time will take time. Please fill out the tenders information in good time before the deadline expires.

VI.4)Procedures for review
VI.4.1)Review body
The Market Court
Radanrakentajantie 5
Helsinki
00520
Finland
Telephone: +358 295643300
E-mail: markkinaoikeus@oikeus.fi
Fax: +358 295643314

Internet address: http://www.markkinaoikeus.fi/en/index.html

VI.4.2)Body responsible for mediation procedures
VI.4.3)Review procedure
VI.4.4)Service from which information about the review procedure may be obtained
VI.5)Date of dispatch of this notice:
12/06/2019